Today (October 29) at 9:00 am, the National Medical Insurance Bureau held a national medical insurance drug and consumables traceability information collection and application release interpretation activities. At the Cyber Blue Medical Device Conference, it was learned that as of October 28, 32 provincial medical insurance information platforms have fully carried out the collection of drug and consumables traceability codes, and 3.127 billion drug and consumables traceability code data have been collected, involving 296,800 designated medical institutions and 497,200 designated retail pharmacies. More than 60% of medical institutions and 99% of pharmacies have carried out the collection of traceability codes.

The National Medical Insurance Bureau has made it clear that it will continue to promote the application of drug and consumables traceability codes in the future, so that every link of drug and consumables from production, transportation to sales can be monitored and recorded in a timely manner, and use big data analysis to timely discover problems, trace the source, and take measures to reassure enterprises and people. It is understood that the drug and consumables traceability code is generally printed on the packaging of drugs and medical consumables in the form of barcodes or QR codes. It is the unique identity of drugs and medical consumables, equivalent to the "electronic ID card" of drugs. Since April, the National Medical Insurance Administration has continued to carry out pilot work on the collection of drug and consumables traceability code information. The relevant person in charge of the National Medical Insurance Administration said that provincial medical insurance departments need to organize self-evaluation of local pilot work, form a pilot work report and report it to the National Medical Insurance Administration. The National Medical Insurance Administration will summarize the experience of each pilot area, refine replicable and popularizable models, and ensure that the scanning code entry work will be fully carried out nationwide before the end of 2024. At present, the National Medical Insurance Administration is building a unified national upload traceability code information interface, striving to achieve one-time upload and national general use. In addition, a new traceability code collection and supervision function will be built to realize the full process supervision of drug circulation from drug manufacturers, distribution companies, hospitals, and pharmacies.

On September 30, the National Medical Insurance Administration issued the "Notice on Further Improving the Collection of Information on Traceability Codes for Medical Insurance Drugs and Consumables", proposing to comprehensively establish a three-in-one mapping library of traceability codes, medical insurance codes and commodity codes, as well as a traceability mapping library for large, medium and small packages of drug consumables, and an identification library for various traceability codes, and open it to designated medical institutions and production and distribution companies free of charge. After the construction of the "three-in-one" mapping library, the scanning code entry and exit work can be further realized to be efficient and convenient, and the scanning work intensity of designated medical institutions and production and distribution companies can be reduced. In terms of quality supervision, for pharmaceutical companies and drug regulatory departments, traceability codes can also help them monitor the production, transportation and sales of drug consumables in real time, and promptly discover and deal with problems. Once the regulatory department finds quality problems with drug consumables, it can also quickly locate the problem batches and circulation through traceability codes, so as to facilitate timely recall and processing. In addition, the medical insurance department can effectively prevent fraud and insurance fraud such as reflux sales, cross-selling, and repeated sales of medical insurance drugs and consumables through the seamless connection of traceability codes with medical insurance settlement services. At the Cyber Blue Medical Devices Conference, it was learned that the medical insurance traceability code management system can also provide assistance to production and distribution companies in product data analysis and price monitoring. Companies can use patients' real usage data and combine "adverse reaction reports" to conduct data analysis; companies can also query terminal prices to avoid the negative impact on production companies if prices are lower than the online prices. In local pilot projects, Xiamen City has achieved the linkage of five codes: drug traceability code, product code, material code, fee code, and medical insurance code. The consumables part has been linked with UDI and material code, fee code, and medical insurance code, and the level of management refinement has been significantly improved. In the next step, the National Medical Insurance Bureau will also fully establish a three-code mapping library for traceability codes, medical insurance codes, and product codes, as well as a traceability mapping library for large, medium, and small packages of drugs and consumables, and an identification library for various traceability codes, and open them to designated medical institutions and production and distribution companies for free to improve the efficiency and convenience of scanning codes for warehousing and outbound warehousing.

https://mp.weixin.qq.com/